Characteristics, Complications, Comorbidities, and Other Manifestations of Inflammatory Bowel Disease: A 7-Year Tertiary Center Experience
Authors:
- Waleed AlharbiWAWaleed Alharbi
- Turki AlasmariTATurki Alasmari
- Najla Al RasheedNRNajla Al Rasheed
- Jamila A. AlonaziJAJamila A. Alonazi
- Naif K. AlaqilNANaif K. Alaqil
- Meshari Al SamihMSMeshari Al Samih
- Nawaf S. AlzahraniNANawaf S. Alzahrani
- Abdulaziz Bin AkrishAAAbdulaziz Bin Akrish
- Soliman AlaraidhSASoliman Alaraidh
Open Access
- 24 February 2026
- journal article
- research article
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (3) , 45
Abstract
Background/Objectives: Inflammatory bowel disease (IBD) is associated with significant morbidity worldwide. While global epidemiological trends are well-documented, data on the clinical and demographic characteristics of IBD patients in Saudi Arabia remain limited. This study aimed to evaluate the distribution of multimorbidity among IBD patients in a tertiary Saudi hospital and assess associated clinical features and outcomes. Methods: A retrospective cross-sectional study of IBD patients treated at the National Guard Hospital over a seven-year period was conducted. Data on demographics, body mass indices (BMIs), hospitalizations, comorbidities, complications, and surgical interventions were extracted from medical records. Associations between categorical and continuous variables were analyzed using chi-square and t-tests, respectively, with significance being set to p < 0.05. Results: A total of 465 patients were included: 54.6% had Crohn’s disease (CD) and 45.4% had ulcerative colitis (UC). CD predominated in males (60.6%), while UC was more common in females (55.5%, p = 0.001). BMI distribution differed significantly between groups (p = 0.004). Hospital admission rates and length of stay were higher among CD patients (p = 0.032). CD patients experienced greater complication rates, including fistulas (41.3% vs. 7.1%, p < 0.001) and strictures (26.1% vs. 1.4%, p < 0.001). Surgical interventions such as fistulotomy (4.3% vs. 0.5%, p = 0.009) and stricturoplasty (9.1% vs. 1.9%, p = 0.001) were more frequent in patients with CD. Conclusions: This study characterizes IBD patients in Saudi Arabia, highlighting gender differences, BMI variations, and the greater severity of CD compared with UC. The higher rates of complications and surgical interventions among CD patients emphasize the need for tailored management strategies. Future prospective studies are warranted to investigate disease progression and optimize care for this population.Keywords
This publication has 36 references indexed in Scilit:
- Inflammation and malnutrition in inflammatory bowel diseaseThe Lancet Gastroenterology & Hepatology, 2023
- Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination SurveyPreventive Medicine Reports, 2023
- Systematic review and meta-analysis: association between obesity/overweight and surgical complications in IBDInternational Journal of Colorectal Disease, 2022
- Prevalence and Risk Factors for Fatigue in Adults With Inflammatory Bowel Disease: A Systematic Review With Meta-AnalysisClinical Gastroenterology and Hepatology, 2022
- Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn’s Disease in Population-Based Cohort StudiesDigestive Diseases and Sciences, 2021
- Management of Inflammatory Bowel Diseases in Special Populations: Obese, Old, or ObstetricClinical Gastroenterology and Hepatology, 2020
- The measurement of multimorbidity.Health Psychology, 2019
- AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert ReviewClinical Gastroenterology and Hepatology, 2019
- Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohnʼs Disease Compared to Men Without Inflammatory Bowel disease: A Nationwide cohort StudyAmerican Journal of Gastroenterology, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesHepatology, 2017